“THE ROLE OF THE AMCP FORMAT: The evidence requirements contained herein are intended for use by manufacturers of pharmaceuticals, biologics and vaccines who are responding to an unsolicited request from a healthcare system to support reimbursement and/or formulary placement consideration of a new product, new indication, or new formulation of an existing product.”A summary of changes is also available on the website; none relate to the methods of economic evaluation as described in Section 4.2 of the Format.